Prof Philip MacCarthy trained in Bristol and Oxford before completing his PhD in endothelial function at the University Hospital of Wales (with an MRC Clinical Training Fellowship).

He went on to train in coronary intervention at King's College Hospital and the OLV Cardiac Centre in Aalst, Belgium.

He was appointed as Consultant Cardiologist at King's College Hospital in 2003 and Clinical Lead for Cardiology in 2007. From 2012-2015 he was Clinical Director of Cardiovascular Services at King's. In 2014 he was appointed Professor of Interventional Cardiology by King's College London.

He specialises in coronary intervention (angioplasty/stenting) and structural heart disease interventions, running the successful patent foramen ovale (PFO)/atrial septal defect (ASD) device closure and trans-catheter valve (aortic valve/TAVI/MitraClip) programmes at King's.

He has an active research programme and his interests include coronary physiology, primary angioplasty, and trans-catheter aortic/mitral interventions.

Diseases, Medical Tests and Treatments

• Angioplasty
• Coronary stent insertion
• Patent foramen ovale (PFO) closure
• Percutaneous closure of PFO/atrial septal defect (ASD)
• Trans-catheter valve therapy (TAVI, MitraClip, other technology)
• Radial (wrist) catheter procedures
• Heart valve problems
• Coronary heart disease
• Ischaemic heart disease/diagnostics
• Angina
• Unstable angina
• Atrial septal defects (ASD)
• Chest pain
• Valvular heart disease
• Cardiovascular defects
• Cardiovascular risk factor management
• Interventional cardiology

It is important that HCA is transparent about our relationship with those doctors who provide us with clinical guidance on delivering the best possible care to patients and operating our hospitals safely and efficiently. We set out here some of the ways in which we work together and the amount we pay this doctor for such services.